Evaluating the Role of Mitochondrial Function in Cancer-related Fatigue
May 17th, 2018
8.7K views
Our goal was to develop a practical protocol to evaluate mitochondrial dysfunction associated with fatigue in cancer patients. This innovative protocol is optimized for clinical use involving only standard phlebotomy and basic laboratory procedures.
Overview
This article presents a practical protocol designed to evaluate mitochondrial dysfunction associated with fatigue in cancer patients. The method is optimized for clinical use, utilizing standard phlebotomy and basic laboratory procedures.
Key Study Components
Area of Science
- Neuroscience
- Clinical oncology
- Metabolic health
Background
- Mitochondrial dysfunction is linked to fatigue in cancer patients.
- Understanding this relationship can enhance supportive cancer care.
- Less invasive techniques are preferred in clinical settings.
- This method may also apply to other fatiguing conditions.
Purpose of Study
- To evaluate mitochondrial dysfunction in cancer-related fatigue.
- To identify patients at risk for toxicities from cancer therapy.
- To advance understanding of fatigue mechanisms in cancer.
Methods Used
- Standard phlebotomy for sample collection.
- Basic laboratory procedures for analysis.
- Injection of respiratory inhibitors into sensor cartridges.
- Visual demonstrations to aid new users of the method.
Main Results
- The technique effectively identifies mitochondrial dysfunction.
- It provides insights into cancer-related fatigue mechanisms.
- It is applicable to other diseases with fatigue symptoms.
Conclusions
- The protocol is practical for clinical use.
- It can improve assessment and management of fatigue in cancer patients.
- Further research may expand its application to other conditions.
Frequently Asked Questions
What is the main goal of this study?
The main goal is to evaluate mitochondrial dysfunction associated with fatigue in cancer patients.
How is the method described in the article performed?
It involves standard phlebotomy and basic laboratory procedures.
What are the advantages of this technique?
It is less invasive and can be easily used in clinical settings.
Can this method be applied to other conditions?
Yes, it can also be applied to other fatiguing diseases.
What challenges might new users face?
New users may find it challenging to inject respiratory inhibitors without prior visual demonstration.
How does this study contribute to cancer care?
It advances understanding of mitochondrial dysfunction's role in cancer-related fatigue.
What is the significance of identifying mitochondrial dysfunction?
Identifying it can help optimize management and improve patient outcomes.
Executive Industry Relevance
Mitochondrial dysfunction is increasingly recognized as a mechanistic contributor to cancer-related fatigue, a condition that impacts patient quality of life and may influence treatment tolerance. This protocol enables objective assessment of PBMC mitochondrial function using a compact extracellular flux system, offering a translational tool for de-risking hypotheses in supportive oncology. By providing quantitative readouts such as basal respiration, spare respiratory capacity, and energy phenotype, the method supports target validation and mechanistic insight in fatigue-related pathways.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of mitochondrial function as a potential therapeutic target in cancer-related fatigue.
- Operational Value: Uses minimally invasive phlebotomy to obtain clinically relevant PBMCs for repeated longitudinal sampling.
Screening & Assay Development
- Scientific Value: Generates quantitative, normalized OCR data that enables comparison across time points and treatment conditions.
- Operational Value: Completes in under 4 hours with standardized normalization to live cell count, supporting assay reproducibility and scalability.
Translational & Preclinical Research
- Scientific Value: Links mitochondrial metrics to clinical fatigue scores, enabling correlation of mechanistic data with patient-reported outcomes.
- Operational Value: Adaptable to other fatiguing conditions, broadening utility across metabolic and inflammatory disease models.
Pipeline & Workflow Integration
The method fits within the discovery continuum by providing functional mitochondrial data that can inform target selection and pathway analysis in fatigue-associated signaling.
- Discovery Biology: Supports hypothesis testing around mitochondrial respiration and energy metabolism in immune cells from fatigued patients.
- Screening: Delivers assay-ready, normalized mitochondrial readouts suitable for evaluating compound effects on OCR and spare capacity.
- Analytics: Provides basal, maximal, and spare respiratory capacity measurements that enable quantitative comparison of mitochondrial phenotypes.
- Translational Research: Connects ex vivo mitochondrial function to in vivo fatigue severity, supporting biomarker-aligned study designs.
- Enterprise Reuse: Establishes a standardized, clinic-compatible workflow for longitudinal immune-metabolic monitoring in oncology cohorts.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in cancer-related fatigue by providing direct functional readouts of mitochondrial health.
- Operational Value: Enables standardization across sites via normalization to live cell count and defined inhibitor injection protocols.
- Strategic Value: Supports go/no-go decisions in fatigue-targeted programs by identifying patients with measurable mitochondrial impairment.
- Portfolio Impact: Facilitates risk-stratified advancement of interventions based on objective mitochondrial response to therapy.
Implementation Considerations
- Requires expertise in mitochondrial assay techniques and extracellular flux instrumentation.
- Dependent on access to a calibrated extracellular flux analyzer and sensor cartridges.
- Necessitates standardized training for consistent respiratory inhibitor injection to avoid technical variability.
- Requires optimization of cell density and FCCP concentration for each PBMC donor batch.
- Limited by PBMC viability and functional stability post-isolation, necessitating same-day assay execution.
Biopharma FAQs
Why measure basal and maximal respiration in PBMCs for fatigue studies?
Basal and maximal oxygen consumption rates (OCR) provide insight into mitochondrial functional capacity and reserve, which are diminished in fatigued cancer patients compared to controls, supporting objective assessment of mitochondrial dysfunction.
How does isolating PBMCs enable mitochondrial functional analysis in cancer fatigue?
Freshly isolated PBMCs from cancer patients allow direct measurement of mitochondrial respiration using extracellular flux analysis, enabling evaluation of immune cell bioenergetics linked to fatigue severity.
What does spare respiratory capacity reveal about mitochondrial function in fatigued patients?
Spare respiratory capacity, calculated as the difference between maximal and basal OCR, is reduced in fatigued subjects, indicating diminished ability to respond to energetic stress, a key functional deficit in cancer-related fatigue.
Why is normalization to live cell count essential for reproducible mitochondrial data?
Normalizing OCR to live cell count, quantified via nucleic acid staining, accounts for variability in cell number and viability, ensuring that mitochondrial measurements reflect true functional differences rather than technical artifacts.
What statistical analysis is needed to compare mitochondrial function between fatigued and control groups?
Comparisons require normalization of OCR data followed by statistical testing to assess significant differences in basal respiration, maximal OCR, and spare capacity, as demonstrated in the protocol’s validation with healthy and fatigued subjects.
Chapters in this video
0:04
Title
1:26
Mitochondrial Function Measurement and Clinical Sample Preparation (Day 1 and 2 of the Experiment)
2:16
Mitochondrial Function Measurement
5:21
Normalization of Mitochondrial Functional Data
6:13
Results: Use of Mito Stress Test to Diagnose Dysfunction in Fatigued Cancer Patients
7:34
Conclusion
